Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 -0.02 (-5.09%)
As of: Oct 21, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Construction in Progress (2016)

Updated

Citius Pharmaceuticals (CTXR) posted Construction in Progress of $19.4 million for fiscal Q2 2016 (quarter ended Mar 31, 2016).

Analysis

Citius Pharmaceuticals (CTXR) Construction in Progress (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Citius Pharmaceuticals 10.37 Mn -23.20 Mn 1.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 19.40 Mn
API Access

Citius Pharmaceuticals Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=CTXR&period=max&api_key=YOUR_API_KEY